Veracyte (VCYT) EPS (Diluted) Growth (3y) (2022 - 2026)
Veracyte (VCYT) EPS (Diluted) Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 10.52% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -6.10% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 16.91% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 5.61% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -2.93% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 21.11% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 42.83% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 6.03% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 10.87% |
| 10 | Veracyte | 3.68 Bn | 3.38 Bn | 108.55 Mn | 67.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 67.26% |
| Mar 31, 2026 | 72.68% |
| Dec 31, 2025 | 126.36% |
| Sep 30, 2025 | 58.31% |
| Jun 30, 2025 | 54.57% |
| Mar 31, 2025 | 34.49% |
| Dec 31, 2024 | 34.22% |
| Sep 30, 2024 | 43.47% |
| Jun 30, 2024 | 36.78% |
| Mar 31, 2024 | 66.46% |
| Dec 31, 2023 | -37.09% |
| Sep 30, 2023 | -75.47% |
| Jun 30, 2023 | 19.26% |
| Mar 31, 2023 | 23.86% |
| Dec 31, 2022 | 30.93% |